Vanilloids and their effect on mammalian biological barriers

Capsaicin: Food Sources, Medical Uses and Health Implications

Volumn , Issue , 2014, Pages 53-73

  Kaiser, Mathias ^a   Goycoolea, Francisco M ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84955414069     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (79)

1. Wahyuni Y, Ballester A-, Sudarmonowati E, Bino RJ, Bovy AG. Secondary metabolites of capsicum species and their importance in the human diet. J. Nat. Prod. 2013;76(4):783-93.
2. Meghvansi MK, Siddiqui S, Khan MH, Gupta VK, Vairale MG, Gogoi HK, et al., Naga chilli: A potential source of capsaicinoids with broadspectrum ethnopharmacological applications. J. Ethnopharmacol. 2010 OCT 28;132(1):1-14.
3. Turgut C, Newby B-, Cutright TJ. Determination of optimal water solubility of capsaicin for its usage as a non-toxic antifoulant. Environmental Science and Pollution Research. 2004;11(1):7-10.
4. Jancsó N, Jancsó-Gábor A, Szolcsányi J. Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br. J. Pharmacol. 1967;31(1):138-51.
5. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: A heat-activated ion channel in the pain pathway. Nature. 1997;389(6653):816-24.
6. Julius D, Basbaum AI. Molecular mechanisms of nociception. Nature. 2001;413(6852):203-10.
7. Scoville WL. Note on capsicums. J. Am. Pharm. Assoc. 1912;1(5):453-4.
8. Smith H, Brooks JR. Capsaicin-based therapies for pain control. In: Abdel-Salam OME, editor. Capsaicin as a Therapeutic Molecule. Springer Basel; 2014. p. 129-46.
9. Schumacher M, Pasvankas G. Topical capsaicin formulations in the management of neuropathic pain. In: Abdel-Salam OME, editor. Capsaicin as a Therapeutic Molecule. Springer Basel; 2014. p. 105-28.
10. Leung FW. Capsaicin as an anti-obesity drug. In: Abdel-Salam OME, editor. Capsaicin as a Therapeutic Molecule. Springer Basel; 2014. p. 171-9.
11. Zhang LL, Liu DY, Ma LQ, Luo ZD, Cao TB, Zhong J, et al., Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity. Circ. Res. 2007;100(7):1063-70.
12. Han J, Isoda H. Capsaicin induced the upregulation of transcriptional and translational expression of glycolytic enzymes related to energy metabolism in human intestinal epithelial cells. J. Agric. Food Chem. 2009;57(23):11148-53.
13. Steiner AA, Turek VF, Almeida MC, Burmeister JJ, Oliveira DL, Roberts JL, et al., Nonthermal activation of transient receptor potential vanilloid-1 channels in abdominal viscera tonically inhibits autonomic cold-defense effectors. Journal of Neuroscience. 2007;27(28):7459-68.
14. Díaz-Laviada I, Rodríguez-Henche N. The potential antitumor effects of capsaicin. In: Abdel-Salam OME, editor. Capsaicin as a Therapeutic Molecule. Springer Basel; 2014. p. 181-208.
15. Foster Jr. HE, Lake AG. Use of vanilloids in urologic disorders. In: Abdel-Salam OME, editor. Capsaicin as a Therapeutic Molecule. Springer Basel; 2014. p. 307-17.
16. Mózsik G, Past T, Habon T, Keszthelyi Z, Perjési P, Kuzma M, et al., Capsaicin is a new gastrointestinal mucosal protecting drug candidate in humans. In: Gyula Mozsik, editor. Capsaicin-Sensitive Neural Afferentation and the Gastrointestinal Tract: from Bench to Bedside. AvE4EvA; 2014. p. 209-308.
17. Shiobara T, Usui T, Han J, Isoda H, Nagumo Y. The reversible increase in tight junction permeability induced by capsaicin is mediated via cofilin-actin cytoskeletal dynamics and decreased level of occludin. PLoS ONE. 2013;8(11).
18. Cordell GA, Araujo OE, Burgos GAS, Perreault M. Capsaicin: Identification, nomenclature, and pharmacotherapy. Ann. Pharmacother. 1993;27(3):330-6.
19. Fang J-, Fang C-, Hong C-, Chen H-, Lin T-, Wei H. Capsaicin and nonivamide as novel skin permeation enhancers for indomethacin. European Journal of Pharmaceutical Sciences. 2000;12(3):195-203.
20. Lunter D, Daniels R. In vitro skin permeation and penetration of nonivamide from novel film-forming emulsions. Skin Pharmacology and Physiology. 2013;26(3):139-46.
21. Rottke M, Lunter DJ, Daniels R. In vitro studies on release and skin permeation of nonivamide from novel oil-in-oil-emulsions. European Journal of Pharmaceutics and Biopharmaceutics. 2014;86(2):260-6.
22. Yang J-, Tang C-, Yu K-, Yang Y-, Chang W-, Chen I. Sodium nonivamide acetate: A non-pungently antinociceptive capsaicin derivative with unusual anti-inflammatory properties. Gen Pharmacol. 1996;27(1):141-50.
23. Huang YB, Lin YH, Lu TM, Wang RJ, Tsai YH, Wu PC. Transdermal delivery of capsaicin derivative-sodium nonivamide acetate using microemulsions as vehicles. Int. J. Pharm. 2008;349(1-2):206-11.
24. Bevan S, Hothi S, Hughes G, James IF, Rang HP, Shah K, et al., Capsazepine: A competitive antagonist of the sensory neurone excitant capsaicin. Br. J. Pharmacol. 1992;107(2):544-52.
25. Iida T, Moriyama T, Kobata K, Morita A, Murayama N, Hashizume S, et al., TRPV1 activation and induction of nociceptive response by a non pungent capsaicin-like compound, capsiate. Neuropharmacology. 2003 6;44(7):958-67.
26. Van Itallie CM, Anderson JM. Claudins and epithelial paracellular transport. Annual Review of Physiology. 2006;68:403-29.
27. Yap AS, Brieher WM, Gumbiner BM. Molecular and functional analysis of cadherin-based adherens junctions. Annual Review of Cell and Developmental Biology. 1997;13:119-46.
28. Furuse M, Fujita K, Hiiragi T, Fujimoto K, Tsukita S. Claudin-1 and -2: Novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J. Cell Biol. 1998;141(7):1539-50.
29. Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S, et al., Occludin: A novel integral membrane protein localizing at tight junctions. J Cell Biol. 1993;123(6 PART 2):1777-88.
30. Martìn-Padura I, Lostaglio S, Schneemann M, Williams L, Romano M, Fruscella P, et al., Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J. Cell Biol. 1998;142(1):117-27.
31. Aurrand-Lions M, Duncan L, Ballestrem C, Imhof BA. JAM-2, a novel immunoglobulin superfamily molecule, expressed by endothelial and lymphatic cells. J. Biol. Chem. 2001;276(4):2733-41.
32. Stevenson BR, Siliciano JD, Mooseker MS, Goodenough DA. Identification of ZO-1: A high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia. J. Cell Biol. 1986;103(3):755-66.
33. Gumbiner B, Lowenkopf T, Apatira D. Identification of a 160-kDa polypeptide that binds to the tight junction protein ZO-1. Proc. Natl. Acad. Sci. USA. 1991;88(8):3460-4.
34. Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nature Reviews Molecular Cell Biology. 2001;2(4):285-93.
35. Sonaje K, Lin K, Wang J, Mi F, Chen C, Juang J, et al., Self-assembled pH-sensitive nanoparticles: A platform for oral delivery of protein drugs. Advanced Functional Materials. 2010;20(21):3695-700.
36. Chen Y, Liu L. Modern methods for delivery of drugs across the blood-brain barrier. Adv. Drug Deliv. Rev. 2012 5/15;64(7):640-65.
37. Yeh T, Hsu L, Tseng MT, Lee P, Sonjae K, Ho Y, et al., Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening. Biomaterials. 2011 9;32(26):6164-73.
38. Kemper B, Carl D, Höink A, Von Bally G, Bredebusch I, Schnekenburger J. Modular digital holographic microscopy system for marker free quantitative phase contrast imaging of living cells. Progress in biomedical optics and imaging-proceedings of SPIE;; 2006.
39. Barer R. Interference microscopy and mass determination. Nature. 1952;169(4296):366-7.
40. Siflinger-Birnboim A, Del Vecchio PJ, Cooper JA, Blumenstock FA, Shepard JM, Malik AB. Molecular sieving characteristics of the cultured endothelial monolayer. J. Cell Physiol. 1987;132(1):111-7.
41. Volpe DA. Drug-permeability and transporter assays in caco-2 and MDCK cell lines. Future Medicinal Chemistry. 2011;3(16):2063-77.
42. Irvine JD, Takahashi L, Lockhart K, Cheong J, Tolan JW, Selick HE, et al., MDCK (madin-darby canine kidney) cells: A tool for membrane permeability screening. J. Pharm Sci. 1999;88(1):28-33.
43. Gekle M, Wünsch S, Oberleithner H, Silbernagl S. Characterization of two MDCK-cell subtypes as a model system to study principal cell and intercalated cell properties. Pflügers Archiv European Journal of Physiology. 1994;428(2):157-62.
44. Volpe DA. Variability in caco-2 and MDCK cell-based intestinal permeability assays. J. Pharm Sci. 2008;97(2):712-25.
45. van Breemen R,B., Li Y. Caco-2 cell permeability assays to measure drug absorption. Expert Opin. Drug Metab. Toxicol. 2005 08/01; 2014/07;1(2):175-85.
46. Artursson P, Karlsson J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (caco-2) cells. Biochem. Biophys. Res. Commun. 1991 3/29;175(3):880-5.
47. Crone C, Christensen O. Electrical resistance of a capillary endothelium. The Journal of General Physiology. 1981 April 01;77(4):349-71.
48. Crone C, Olesen SP. Electrical resistance of brain microvascular endothelium. Brain Res. 1982 6/3;241(1):49-55.
49. Rutten MJ, Hoover RL, Karnovsky MJ. Electrical resistance and macromolecular permeability of brain endothelial monolayer cultures. Brain Res. 1987;425(2):301-10.
50. Benson K, Cramer S, Galla H. Impedance-based cell monitoring: Barrier properties and beyond. Fluids and Barriers of the CNS. 2013;10(1).
51. Lazarides E, Weber K. Actin antibody: The specific visualization of actin filaments in non-muscle cells. Proceedings of the National Academy of Sciences. 1974 June 01;71(6):2268-72.
52. Isoda H, Han J, Tominaga M, Maekawa T. Effects of capsaicin on human intestinal cell line caco-2. Cytotechnology. 2001;36(1-3):155-61.
53. Han J, Isoda H, Maekawa T. Analysis of the mechanism of the tightjunctional permeability increase by capsaicin treatment on the intestinal caco-2 cells. Cytotechnology. 2003;40(1-3):93-8.
54. Han J, Akutsu M, Talorete TPN, Maekawa T, Tanaka T, Isoda H. Erratum: Capsaicin-enhanced ribosomal protein P2 expression in human intestinal caco-2 cells (cytotechnology 47 (89-96)). Cytotechnology. 2005;49(1):77-85.
55. Nagumo Y, Han J, Arimoto M, Isoda H, Tanaka T. Capsaicin induces cofilin dephosphorylation in human intestinal cells: The triggering role of cofilin in tight-junction signaling. Biochem. Biophys. Res. Commun. 2007 4/6;355(2):520-5.
56. Tsukura Y, Mori M, Hirotani Y, Ikeda K, Amano F, Kato R, et al., Effects of capsaicin on cellular damage and monolayer permeability in human intestinal caco-2 cells. Biological and Pharmaceutical Bulletin. 2007;30(10):1982-6.
57. Jensen-Jarolim E, Gajdzik L, Haberl I, Kraft D, Scheiner O, Graf J. Hot spices influence permeability of human intestinal epithelial monolayers. J. Nutr. 1998;128(3):577-81.
58. Fang J-, Wu P-, Huang Y-, Tsai Y. In vitro permeation study of capsaicin and its synthetic derivatives from ointment bases using various skin types. Int. J. Pharm. 1995;126(1-2):119-28.
59. Zhang Y, Xiang B, Li Y, Wang Y, Wang X, Wang Y, et al., Expression and characteristics of vanilloid receptor 1 in the rabbit submandibular gland. Biochem. Biophys. Res. Commun. 2006 6/23;345(1):467-73.
60. Ding QW, Zhang Y, Wang Y, Wang YN, Zhang L, Ding C, et al., Functional vanilloid receptor-1 in human submandibular glands. J. Dent Res. 2010;89(7):711-6.
61. Cong X, Zhang Y, Shi L, Yang N-, Ding C, Li J, et al., Activation of transient receptor potential vanilloid subtype 1 increases expression and permeability of tight junction in normal and hyposecretory submandibular gland. Laboratory Investigation. 2012;92(5):753-68.
62. Cong X, Zhang Y, Yang N-, Li J, Ding C, Ding Q-, et al., Occludin is required for TRPV1-modulated paracellular permeability in the submandibular gland. J. Cell Sci. 2013;126(5):1109-21.
63. Brown RC, Wu L, Hicks K, O'Neil RG. Regulation of blood-brain barrier permeability by transient receptor potential type C and type V calcium-permeable channels. Microcirculation. 2008;15(4):359-71.
64. Beggs S, Liu XJ, Kwan C, Salter MW. Peripheral nerve injury and TRPV1-expressing primary afferent C-fibers cause opening of the blood-brain barrier. Molecular Pain. 2010;6.
65. Hu D, Easton A, Fraser P. TRPV1 activation results in disruption of the blood-brain barrier in the rat. Br. J. Pharmacol. 2005 OCT;146(4):576-84.
66. Xanthos DN, Püngel I, Wunderbaldinger G, Sandkühler J. Effects of peripheral inflammation on the blood-spinal cord barrier. Molecular Pain. 2012;8.
67. Komori Y, Aiba T, Sugiyama R, Nakai C, Kawasaki H, Kurosaki Y. Effects of capsaicin on intestinal cephalexin absorption in rats. Biological and Pharmaceutical Bulletin. 2007;30(3):547-51.
68. Wenzel U, Kuntz S, Diestel S, Daniel H. PEPT1-mediated cefixime uptake into human intestinal epithelial cells is increased by Ca2+ channel blockers. Antimicrob Agents Chemother. 2002;46(5):1375-80.
69. Philip G, Baroody FM, Proud D, Naclerio RM, Togias AG. The human nasal response to capsaicin. J. Allergy Clin. Immunol. 1994;94(6 I):1035-45.
70. Asakura K, Shirasaki H, Narita S, Kojima T, Kataura A. Study on the dye leakage response of nasal mucosa following topical, capsaicin challenge in guinea pigs. Acta Otolaryngol. 1992;112(3):545-51.
71. Lundblad L, Saria A, Lundberg JM, Anggard A. Increased vascular permeability in rat nasal mucosa induced by substance P and stimulation of capsaicin-sensitive trigeminal neurons. Acta Otolaryngol. 1983;96(5-6):479-84.
72. Xing F, Cheng G, Yang B, Ma L. Microencapsulation of capsaicin by the complex coacervation of gelatin, acacia and tannins. J. Appl. Polym. Sci. 2004;91(4):2669-75.
73. Xing F, Cheng G, Yi K. Study on the antimicrobial activities of the capsaicin microcapsules. J. Appl. Polym. Sci. 2006;102(2):1318-21.
74. Choi A-, Kim C-, Cho Y-, Hwang J-, Kim C. Characterization of capsaicin-loaded nanoemulsions stabilized with alginate and chitosan by self-assembly. Food and Bioprocess Technology. 2011;4(6):1119-26.
75. Goycoolea FM, Valle-Gallego A, Stefani R, Menchicchi B, David L, Rochas C, et al., Chitosan-based nanocapsules: Physical characterization, stability in biological media and capsaicin encapsulation. Colloid Polym. Sci. 2012;290(14):1423-34.
76. Jincheng W, Sihao C. Preparation and characterization of microcapsules containing capsaicin. J. Appl. Polym. Sci. 2010;116(4):2234-41.
77. Zhu Y, Peng W, Zhang J, Wang M, Firempong CK, Feng C, et al., Enhanced oral bioavailability of capsaicin in mixed polymeric micelles: Preparation, in vitro and in vivo evaluation. Journal of Functional Foods. 2014;8(1):358-66.
78. Choi AY, Kim C-, Park HY, Kim HO, Lee NR, Lee KE, et al., Pharmacokinetic characteristics of capsaicin-loaded nanoemulsions fabricated with alginate and chitosan. J. Agric. Food Chem. 2013;61(9):2096-102.
79. Kim JH, Ko JA, Kim JT, Cha DS, Cho JH, Park HJ, et al., Preparation of a capsaicin-loaded nanoemulsion for improving skin penetration. J. Agric. Food Chem. 2014;62(3):725-32.